Detalhe da pesquisa
1.
Granulomatous Dermatitis Heralding Myelodisplastic/Myeloproliferative Neoplasms. Neoplastic or Reactive Cells? A Study of 2 Cases.
Am J Dermatopathol
; 44(6): 456-460, 2022 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35170471
2.
Inflammatory Cells in Atypical Eruption of Lymphocyte Recovery Carry the Same Mutations as Neoplastic Myeloid Cells.
Am J Dermatopathol
; 42(5): 360-363, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31592861
3.
Analysis of Potential Alterations Affecting SETBP1 as a Novel Contributing Mechanism to Inhibit PP2A in Colorectal Cancer Patients.
World J Surg
; 42(11): 3771-3778, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29796729
4.
Activation of MET pathway predicts poor outcome to cetuximab in patients with recurrent or metastatic head and neck cancer.
J Transl Med
; 13: 282, 2015 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26319934
5.
Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer.
BMC Pulm Med
; 15: 132, 2015 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26502926
6.
Pyrosequencing-Based Assays for Rapid Detection of HER2 and HER3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting HER3 in Retroperitoneal Leiomyosarcoma.
Int J Mol Sci
; 16(8): 19447-57, 2015 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26287187
7.
Mutual regulation between BCL6 and a specific set of miRNAs controls TFH phenotype in peripheral T-cell lymphoma.
Br J Haematol
; 182(4): 587-590, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28699695
8.
Redefining the high-grade B cell lymphoma with double/triple rearrangements of MYC and BCL2/BCL6 genes. Learning from a case report.
EJHaem
; 3(1): 171-174, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846201
9.
Comprehensive Approach to Genomic and Immune Profiling: Insights of a Real-World Experience in Gynecological Tumors.
Diagnostics (Basel)
; 12(8)2022 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36010253
10.
Lymphoplasmacytic lymphoma associated with diffuse large B-cell lymphoma: Progression or divergent evolution?
PLoS One
; 15(11): e0241634, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33180881
11.
Autocrine CCL5 Effect Mediates Trastuzumab Resistance by ERK Pathway Activation in HER2-Positive Breast Cancer.
Mol Cancer Ther
; 19(8): 1696-1707, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32404410
12.
Validation and clinical application of a targeted next-generation sequencing gene panel for solid and hematologic malignancies.
PeerJ
; 8: e10069, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33083132
13.
The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer.
Cancers (Basel)
; 12(5)2020 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32365528
14.
Recent Insights into the Development of Preclinical Trastuzumab- Resistant HER2+ Breast Cancer Models.
Curr Med Chem
; 25(17): 1976-1998, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-27993109
15.
Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer.
Clin Cancer Res
; 23(22): 7006-7019, 2017 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28821558
16.
Determination of True ERBB2 Gene Amplification in Breast Cancer by Quantitative PCR Using a Reference and a Novel Control Gene.
Appl Immunohistochem Mol Morphol
; 24(3): 179-87, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25789534
17.
Generation, characterization, and maintenance of trastuzumab-resistant HER2+ breast cancer cell lines.
Am J Cancer Res
; 6(11): 2661-2678, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27904779
18.
c-Jun N-Terminal Kinase Inactivation by Mitogen-Activated Protein Kinase Phosphatase 1 Determines Resistance to Taxanes and Anthracyclines in Breast Cancer.
Mol Cancer Ther
; 15(11): 2780-2790, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27599524
19.
Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis.
Vet Immunol Immunopathol
; 103(1-2): 67-75, 2005 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-15626462
20.
Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-кB target genes in human breast cancer.
Oncotarget
; 5(1): 196-210, 2014 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24344116